COMP <GO>
PETS vs CVS // 10Y YIELD & FRED MACRO BETA
PetMed Express Inc. (NASDAQ) VS. CVS Health Corporation (NYSE) • 15-METRIC TALLY: PETS 0
— CVS 10
■ METRIC PARITY
LAST: $1.19 (+0.85%) • MKT CAP: $25.6M
macro-sensitivity
—
LAST: $90.25 (-0.09%) • MKT CAP: $115.53B
macro-sensitivity
0.88
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PETS VS. CVS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PETS | CVS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.10% | 45.00% | -16.90 | CVS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 2.60% | -37.60 | CVS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 25.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 6.76% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -32.80% | 1.20% | -34.00 | CVS | /operating-margins <GO> |
| Net Profit Margin | -32.00% | 0.40% | -32.40 | CVS | /net-margins <GO> |
| Revenue Growth (YoY) | -21.10% | 7.80% | -28.90 | CVS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.08% | 2.94% | -2.86 | CVS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.24 | 2.31 | -2.07 | CVS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | CVS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.1 | 47.8 | -14.70 | CVS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.88 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 60.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $25.6M | $115.53B | -$115.50B | CVS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PETS REV | CVS REV | PETS GROSS % | CVS GROSS % | PETS FCF | CVS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $179.0M | $402.07B | 28.1% | 45.0% | -$33.0M | $7.81B |
| FY 2024 | $227.0M | $372.81B | 30.5% | 44.7% | -$395.0K | $6.33B |
| FY 2023 | $274.1M | $357.78B | — | — | $4.3M | -$2.67B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PETS // BETA —
CVS // BETA 0.88